Blann, Andrew D.
Andrew D Blann
Blann, Andrew
VIAF ID: 29041240 (Personal)
Permalink: http://viaf.org/viaf/29041240
Preferred Forms
- 100 0 _ ‡a Andrew D Blann
- 100 1 _ ‡a Blann, Andrew
-
-
-
- 100 1 _ ‡a Blann, Andrew D.
-
-
- 100 1 _ ‡a Blann, Andrew D.
-
- 100 1 _ ‡a Blann, Andrew D.
- 100 1 _ ‡a Blann, Andrew D.
- 100 1 _ ‡a Blann, Andrew D.
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
ABC of antithrombotic therapy, 2003: | |
Blood science : principles and pathology | |
Data Handling and Analysis | |
Deep vein thrombosis and pulmonary embosis | |
Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases | |
The endotheliome: a new concept in vascular biology | |
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state? | |
Ethnic differences in macrovascular and microvascular function in systolic heart failure | |
Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease | |
Haematology | |
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients | |
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men | |
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation | |
Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK. | |
Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes | |
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology? | |
Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment | |
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation | |
Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis | |
Laboratory monitoring of the non-vitamin K oral anticoagulants | |
Left ventricular fibrosis in atrial fibrillation | |
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment | |
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability. | |
Microparticles and arterial disease | |
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection | |
Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population | |
No effect of clopidogrel activity or cessation on vascular function or markers of inflammation | |
The Number of GT(n) Repeats in the Hemeoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory Markers. | |
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. | |
Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project | |
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation | |
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes | |
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension | |
Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity | |
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion | |
Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis | |
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy | |
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project | |
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm | |
Post-stroke inflammatory response: effects of stroke evolution and outcome | |
Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation | |
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology | |
Renal, endothelial function, warfarin management, and the CHADS2, CHA2DS2VASc and HAS-BLED scores inpredicting MACE in AF. | |
Routine blood results explained : [a guide for nurses and allied health professionals] | |
Salt intake and Helicobacter pylori infection | |
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients | |
Soluble adhesion molecules and coronary heart disease | |
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty | |
Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature | |
Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia. | |
Soluble Fas and Fas ligand in pregnancy: influence of hypertension | |
Systemic and intracardiac vascular endothelial growth factor and angiopoietin‐1 and ‐2 levels in coronary artery disease: Effects of angioplasty | |
Tamoxifen for breast-cancer prevention | |
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood | |
Thrombin as a multi-functional enzyme | |
Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'. | |
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension | |
Thrombosis in clinical practice | |
Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation | |
Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study | |
Vascular and platelet responses to aspirin in patients with coronary artery disease | |
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes | |
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure | |
Venous thromboembolism | |
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). | |
Zakrzepica żył głębokich i zatorowość płucna : poradnik lekarza praktyka |